Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae

J Immunol. 2001 Jul 15;167(2):940-5. doi: 10.4049/jimmunol.167.2.940.

Abstract

Parasite survival and host health may depend on the ability of the parasite to modulate the host immune response by the release of immunomodulatory molecules. Excretory-secretory (ES)-62, one such well-defined molecule, is a major secreted protein of the rodent filarial nematode Acanthocheilonema viteae, and has homologues in human filarial nematodes. Previously we have shown that ES-62 is exclusively associated with a Th2 Ab response in mice. Here we provide a rationale for this polarized immune response by showing that the parasite molecule suppresses the IFN-gamma/LPS-induced production, by macrophages, of bioactive IL-12 (p70), a key cytokine in the development of Th1 responses. This suppression of the induction of a component of the host immune response extends to the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not NO. The molecular mechanism underlying these findings awaits elucidation but, intriguingly, the initial response of macrophages to ES-62 is to demonstrate a low and transient release of these cytokines before becoming refractory to further release induced by IFN-gamma/LPS. The relevance of our observations is underscored by the finding that macrophages recovered from mice exposed to "physiological" levels of ES-62 by the novel approach of continuous release from implanted osmotic pumps in vivo were similarly refractory to release of IL-12, TNF-alpha, IL-6, but not NO, ex vivo. Therefore, our results suggest that exposure to ES-62 renders macrophages subsequently unable to produce Th1/proinflammatory cytokines. This likely contributes to the generation of immune responses with an anti-inflammatory Th2 phenotype, a well-documented feature of filarial nematode infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / metabolism
  • Adjuvants, Immunologic / physiology*
  • Animals
  • Cell Survival / immunology
  • Cells, Cultured
  • Cytokines / biosynthesis*
  • Dipetalonema / immunology*
  • Dose-Response Relationship, Immunologic
  • Drug Combinations
  • Glycoproteins / administration & dosage
  • Glycoproteins / metabolism
  • Glycoproteins / physiology*
  • Helminth Proteins / administration & dosage
  • Helminth Proteins / metabolism
  • Helminth Proteins / physiology*
  • Immunosuppressive Agents / pharmacology
  • Infusion Pumps, Implantable
  • Interferon-gamma / antagonists & inhibitors
  • Interferon-gamma / pharmacology
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-12 / biosynthesis
  • Interleukin-12 / genetics
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / biosynthesis
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / pharmacology
  • Macrophage Activation / immunology
  • Macrophages, Peritoneal / immunology
  • Macrophages, Peritoneal / metabolism*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Nitric Oxide / biosynthesis
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / metabolism
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Drug Combinations
  • ES-62 protein, Acanthocheilonema viteae
  • Glycoproteins
  • Helminth Proteins
  • Immunosuppressive Agents
  • Interleukin-6
  • Lipopolysaccharides
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • Nitric Oxide
  • Interferon-gamma